Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 11,693 | 21,439 | 24,822 | 24,539 | 31,684 |
| Operating Income | -11,693 | -21,439 | -24,822 | -24,539 | -31,684 |
| Other Income | 70 | 4,247 | 545 | 82 | -127 |
| Pre-tax Income | -11,623 | -17,192 | -24,277 | -24,457 | -31,811 |
| Net Income Continuous | -11,623 | -17,192 | -24,277 | -24,457 | -31,811 |
| Net Income | $-11,623 | $-17,192 | $-24,277 | $-24,457 | $-31,811 |
| EPS Basic Total Ops | -2.31 | -6.00 | -9.90 | -10.19 | -16.04 |
| EPS Basic Continuous Ops | -2.31 | -5.99 | -9.97 | -10.13 | -15.98 |
| EPS Diluted Total Ops | -2.31 | -6.00 | -9.90 | -10.19 | -16.04 |
| EPS Diluted Continuous Ops | -2.31 | -5.99 | -9.97 | -10.13 | -15.98 |
| EPS Diluted Before Non-Recurring Items | -2.31 | -7.65 | -9.90 | -10.20 | -16.04 |
| EBITDA(a) | $-11,453 | $-21,174 | $-24,537 | $-24,279 | $-31,465 |